Architect system cardiac markers
Device
Abbott Laboratories
Total Payments
$60,000
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $60,000 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $60,000 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study | Abbott Laboratories | $60,000 | 0 |
Top Doctors Receiving Payments for Architect system cardiac markers
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $60,000 | 2 |
Ad
Manufacturing Companies
- Abbott Laboratories $60,000
Product Information
- Type Device
- Total Payments $60,000
- Total Doctors 0
- Transactions 2
About Architect system cardiac markers
Architect system cardiac markers is a device associated with $60,000 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $60,000 was paid across 2 transactions to 0 doctors.
The most common payment nature for Architect system cardiac markers is "Unspecified" ($60,000, 100.0% of total).
Architect system cardiac markers is associated with 1 research study, including "PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study" ($60,000).